Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Berry

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Blood|August 17, 2019
Oxidative hemolysis due to Wilson diseaseZhaodong Xu, Brian R Berry
Blood|May 8, 2020
MDS/MPN-U with persistent monocytosis, del(20q), and CALR mutation, the great masqueraderZhaodong Xu, Brian R Berry
Postgraduate Medicine|December 6, 2017
Heparin therapyBrian R Berry, Steven Nantel
Annals of Hematology|September 4, 2021
A rare de novo pure erythroid leukemia with JAK2 R683S mutationRebecca Z Xu, Aly Karsan, Zhaodong Xu, et al.
British Journal of Haematology|May 4, 2017
Physical activity, obesity and survival in diffuse large B-cell and follicular lymphoma casesTerry Boyle, Joseph M Connors, Randy D Gascoyne, et al.
Plos One|February 21, 2012
Genetic variation in cell death genes and risk of non-Hodgkin lymphomaJohanna M Schuetz, Denise Daley, Jinko Graham, et al.
Vox Sanguinis|July 26, 2021
Impacts of COVID-19 and elective surgery cancellations on platelet supply and utilization in the Canadian Province of British ColumbiaKevin E Shopsowitz, Christina Lim, Andrew W Shih, et al.
International Journal of Cancer|August 28, 2007
Organochlorines and risk of non-Hodgkin lymphomaJohn J Spinelli, Carmen H Ng, Jean-Philippe Weber, et al.
Haematologica|February 4, 2017
Genetic polymorphism at <i>BCL2</i> as a predictor for rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone efficacy in patients with diffuse large B-cell lymphomaMorteza Bashash, Joseph M Connors, Randy D Gascoyne, et al.
Plos One|October 8, 2013
Non-Hodgkin lymphoma risk and variants in genes controlling lymphocyte developmentJohanna M Schuetz, Denise Daley, Stephen Leach, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Blood|August 17, 2019
Oxidative hemolysis due to Wilson diseaseZhaodong Xu, Brian R Berry
Blood|May 8, 2020
MDS/MPN-U with persistent monocytosis, del(20q), and CALR mutation, the great masqueraderZhaodong Xu, Brian R Berry
Postgraduate Medicine|December 6, 2017
Heparin therapyBrian R Berry, Steven Nantel
Annals of Hematology|September 4, 2021
A rare de novo pure erythroid leukemia with JAK2 R683S mutationRebecca Z Xu, Aly Karsan, Zhaodong Xu, et al.
British Journal of Haematology|May 4, 2017
Physical activity, obesity and survival in diffuse large B-cell and follicular lymphoma casesTerry Boyle, Joseph M Connors, Randy D Gascoyne, et al.
Plos One|February 21, 2012
Genetic variation in cell death genes and risk of non-Hodgkin lymphomaJohanna M Schuetz, Denise Daley, Jinko Graham, et al.
Vox Sanguinis|July 26, 2021
Impacts of COVID-19 and elective surgery cancellations on platelet supply and utilization in the Canadian Province of British ColumbiaKevin E Shopsowitz, Christina Lim, Andrew W Shih, et al.
International Journal of Cancer|August 28, 2007
Organochlorines and risk of non-Hodgkin lymphomaJohn J Spinelli, Carmen H Ng, Jean-Philippe Weber, et al.
Haematologica|February 4, 2017
Genetic polymorphism at <i>BCL2</i> as a predictor for rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone efficacy in patients with diffuse large B-cell lymphomaMorteza Bashash, Joseph M Connors, Randy D Gascoyne, et al.
Plos One|October 8, 2013
Non-Hodgkin lymphoma risk and variants in genes controlling lymphocyte developmentJohanna M Schuetz, Denise Daley, Stephen Leach, et al.
Pageof 2